| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.724 | 0.002 | 0.724 | Raf kinase C inhibitor | 0.345 0.005 DBMET00790 0.722 0.002 DBMET00791 | ||
| 0.689 | 0.004 | 0.689 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.094 0.059 DBMET00790 0.636 0.004 DBMET00791 | ||
| 0.671 | 0.004 | 0.671 | Raf kinase inhibitor | 0.074 0.051 DBMET00790 0.629 0.004 DBMET00791 | ||
| 0.639 | 0.004 | 0.639 | Raf kinase B inhibitor | 0.066 0.036 DBMET00790 0.59 0.004 DBMET00791 | ||
| 0.308 | 0.005 | 0.397 | Gastric antisecretory | 0.089 0.08 DBMET00790 0.397 0.004 DBMET00791 | DBMET00791 | |
| 0.265 | 0.01 | 0.265 | Antibacterial (Helicobacter pylori) | 0.167 0.034 DBMET00791 | ||
| 0.27 | 0.044 | 0.278 | Platelet aggregation inhibitor | 0.278 0.041 DBMET00791 | DBMET00791 | |
| 0.233 | 0.013 | 0.233 | Microtubule formation inhibitor | 0.181 0.025 DBMET00791 | ||
| 0.342 | 0.123 | 0.342 | Calcium channel L-type activator | 0.297 0.16 DBMET00791 | ||
| 0.198 | 0.015 | 0.256 | TIE antagonist | 0.256 0.01 DBMET00791 | DBMET00791 | |
| 0.286 | 0.108 | 0.375 | Prostaglandin dehydrogenase inhibitor | 0.375 0.074 DBMET00791 | DBMET00791 | |
| 0.19 | 0.015 | 0.25 | TIE-2 antagonist | 0.25 0.01 DBMET00791 | DBMET00791 | |
| 0.301 | 0.134 | 0.301 | Antibacterial | |||
| 0.179 | 0.019 | 0.179 | Catalase inhibitor | 0.129 0.031 DBMET00791 | ||
| 0.156 | 0.005 | 0.156 | Potassium channel (Ca-activated) blocker | 0.092 0.012 DBMET00791 | ||
| 0.215 | 0.078 | 0.418 | EphB2 antagonist | 0.418 0.014 DBMET00791 | DBMET00791 | |
| 0.271 | 0.135 | 0.271 | Calpain 2 inhibitor | |||
| 0.236 | 0.137 | 0.236 | Transcription factor NF kappa B inhibitor | |||
| 0.27 | 0.173 | 0.27 | Transcription factor inhibitor | |||
| 0.106 | 0.013 | 0.106 | Potassium channel (ATP-sensitive) blocker | 0.07 0.04 DBMET00790 0.104 0.014 DBMET00791 | ||
| 0.117 | 0.026 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.125 | 0.035 | 0.125 | Folate antagonist | |||
| 0.101 | 0.018 | 0.101 | DNA gyrase inhibitor | 0.064 0.044 DBMET00791 | ||
| 0.135 | 0.054 | 0.135 | Platelet activating factor antagonist | |||
| 0.121 | 0.044 | 0.121 | Platelet activating factor alpha antagonist | |||
| 0.145 | 0.073 | 0.148 | MAP kinase kinase 4 inhibitor | 0.148 0.066 DBMET00790 0.139 0.086 DBMET00791 | DBMET00790 | |
| 0.11 | 0.039 | 0.11 | Potassium channel activator | 0.093 0.057 DBMET00791 | ||
| 0.268 | 0.214 | 0.268 | MAP kinase 1 inhibitor | |||
| 0.103 | 0.06 | 0.103 | Hedgehog signaling inhibitor | 0.089 0.088 DBMET00791 | ||
| 0.073 | 0.031 | 0.073 | Interferon inducer | 0.07 0.035 DBMET00791 | ||
| 0.042 | 0.005 | 0.042 | HCV NS5A inhibitor | 0.03 0.016 DBMET00790 0.038 0.006 DBMET00791 | ||
| 0.063 | 0.032 | 0.063 | Acetylcholine muscarinic agonist | |||
| 0.218 | 0.188 | 0.358 | Calcium channel activator | 0.358 0.044 DBMET00791 | DBMET00791 | |
| 0.081 | 0.051 | 0.081 | Interferon agonist | 0.077 0.056 DBMET00791 | ||
| 0.085 | 0.055 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.091 | 0.062 | 0.091 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.097 | 0.069 | 0.097 | mTOR complex 1 inhibitor | |||
| 0.052 | 0.025 | 0.052 | Acetylcholine M1 receptor agonist | |||
| 0.059 | 0.034 | 0.059 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.046 | 0.022 | 0.046 | Factor XIa inhibitor | |||
| 0.048 | 0.025 | 0.048 | Geranyltranstransferase inhibitor | |||
| 0.085 | 0.063 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.061 | 0.041 | 0.061 | Alpha 2 adrenoreceptor agonist | |||
| 0.06 | 0.041 | 0.06 | Bcl-xL inhibitor | |||
| 0.067 | 0.048 | 0.067 | Alpha adrenoreceptor agonist | |||
| 0.023 | 0.005 | 0.023 | Granulocyte colony stimulating factor receptor agonist | 0.021 0.006 DBMET00790 0.022 0.005 DBMET00791 | ||
| 0.187 | 0.169 | 0.187 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.051 | 0.035 | 0.281 | H+/K+-transporting ATPase inhibitor | 0.281 0.004 DBMET00791 | DBMET00791 | |
| 0.036 | 0.021 | 0.036 | Factor XI inhibitor | |||
| 0.192 | 0.179 | 0.192 | Angiogenesis inhibitor | |||
| 0.109 | 0.101 | 0.113 | Cytokine production inhibitor | 0.113 0.096 DBMET00791 | DBMET00791 | |
| 0.029 | 0.022 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.084 | 0.079 | 0.084 | Potassium channel (Voltage-sensitive) activator | |||
| 0.035 | 0.038 | 0.044 | Acetyl-CoA transferase 1 inhibitor | 0.044 0.024 DBMET00791 | DBMET00791 | |
| 0.098 | 0.109 | 0.114 | Bone formation stimulant | 0.114 0.091 DBMET00791 | DBMET00791 | |
| 0.042 | 0.058 | 0.055 | Potassium channel (Inward rectifier) activator | 0.055 0.027 DBMET00791 | DBMET00791 | |
| 0.04 | 0.057 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 DBMET00791 | DBMET00791 | |
| 0.041 | 0.061 | 0.048 | Acetyl-CoA transferase inhibitor | 0.048 0.045 DBMET00791 | DBMET00791 | |
| 0.132 | 0.167 | 0.242 | Platelet antagonist | 0.242 0.076 DBMET00791 | DBMET00791 | |
| 0.168 | 0.223 | 0.237 | Antithrombotic | 0.237 0.137 DBMET00791 | DBMET00791 | |
| 0.04 | 0.096 | 0.127 | DNA helicase inhibitor | 0.127 0.004 DBMET00790 | DBMET00790 | |
| 0.026 | 0.088 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.012 DBMET00791 | DBMET00791 | |
| 0.07 | 0.145 | 0.256 | MAP kinase 12 inhibitor | 0.256 0.011 DBMET00791 | DBMET00791 | |
| 0.039 | 0.122 | 0.082 | ZAP-70 protein tyrosine kinase inhibitor | 0.082 0.032 DBMET00790 | DBMET00790 | |
| 0.061 | 0.16 | 0.248 | MAP kinase 13 inhibitor | 0.248 0.011 DBMET00791 | DBMET00791 | |
| 0.008 | 0.12 | 0.042 | Histone deacetylase 10 inhibitor | 0.042 0.015 DBMET00791 | DBMET00791 | |
| 0.009 | 0.133 | 0.03 | Histone deacetylase 4 inhibitor | 0.03 0.023 DBMET00791 | DBMET00791 | |
| 0.011 | 0.168 | 0.038 | Histone deacetylase 11 inhibitor | 0.038 0.018 DBMET00791 | DBMET00791 | |
| 0.011 | 0.168 | 0.038 | Histone deacetylase class IV inhibitor | 0.038 0.018 DBMET00791 | DBMET00791 | |
| 0.094 | 0.28 | 0.316 | Cardiotonic | 0.316 0.05 DBMET00791 | DBMET00791 | |
| 0.063 | 0.268 | 0.126 | MAP3K9 inhibitor | 0.126 0.102 DBMET00790 | DBMET00790 | |
| 0.041 | 0.252 | 0.133 | Alkylator | 0.133 0.057 DBMET00791 | DBMET00791 | |
| 0.009 | 0.232 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET00790 | DBMET00790 | |
| 0.047 | 0.276 | 0.19 | Cyclooxygenase inhibitor | 0.19 0.046 DBMET00790 | DBMET00790 | |
| 0.035 | 0.299 | 0.182 | Cyclooxygenase 2 inhibitor | 0.182 0.037 DBMET00790 | DBMET00790 | |
| 0.028 | 0.297 | 0.095 | Telomerase inhibitor | 0.095 0.036 DBMET00790 | DBMET00790 | |
| 0.008 | 0.277 | 0.032 | Liver X receptor antagonist | 0.032 0.021 DBMET00790 | DBMET00790 | |
| 0.042 | 0.368 | 0.453 | Interleukin 1 antagonist | 0.453 0.005 DBMET00791 | DBMET00791 | |
| 0.061 | 0.387 | 0.214 | DNA damaging | 0.214 0.105 DBMET00791 | DBMET00791 | |
| 0.014 | 0.344 | 0.082 | MAP kinase 11 inhibitor | 0.082 0.046 DBMET00791 | DBMET00791 | |
| 0.041 | 0.392 | 0.348 | Interleukin antagonist | 0.348 0.039 DBMET00791 | DBMET00791 | |
| 0.068 | 0.458 | 0.205 | Death-associated protein kinase 2 inhibitor | 0.205 0.031 DBMET00791 | DBMET00791 | |
| 0.007 | 0.402 | 0.057 | Liver X receptor agonist | 0.057 0.018 DBMET00790 | DBMET00790 | |
| 0.086 | 0.543 | 0.34 | Peptidyltransferase inhibitor | 0.34 0.014 DBMET00791 | DBMET00791 | |
| 0.019 | 0.524 | 0.082 | Viral attachment inhibitor | 0.082 0.044 DBMET00791 | DBMET00791 | |
| 0.025 | 0.559 | 0.253 | Interleukin 1b antagonist | 0.253 0.012 DBMET00791 | DBMET00791 | |
| 0.042 | 0.603 | 0.427 | Toll-Like receptor agonist | 0.427 0.05 DBMET00790 | DBMET00790 | |
| 0.04 | 0.619 | 0.416 | Toll-Like receptor 7 agonist | 0.416 0.054 DBMET00790 | DBMET00790 | |
| 0.02 | 0.643 | 0.378 | Interleukin 6 antagonist | 0.378 0.009 DBMET00791 | DBMET00791 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |